MENU

en menu

Articles

  • KSBNS 2024

Article Tools

View Full Text Abstract
Article as PDF Print this Article
Pubmed PMC
PubReader Export to Citation
Email Alerts Open Access

Share this article on :

Stats or Metrics

Related articles in EN

Article

Review Article

Exp Neurobiol 2023; 32(6): 371-386

Published online December 31, 2023

https://doi.org/10.5607/en23040

© The Korean Society for Brain and Neural Sciences

Arcuate Nucleus of the Hypothalamus: Anatomy, Physiology, and Diseases

Juhyun Song1* and Seok-Yong Choi2*

1Department of Anatomy, Chonnam National University Medical School, Hwasun 58128,
2Department of Biomedical Sciences, Chonnam National University Medical School, Hwasun 58128, Korea

Correspondence to: *To whom correspondence should be addressed.
Juhyun Song, TEL: 82-61-379-2706, FAX: 82-61-379-2560
e-mail: juhyunsong@chonnam.ac.kr
Seok-Yong Choi, TEL: 82-61-379-2673, FAX: 82-61-379-2560
e-mail: zebrafish@chonnam.ac.kr

Received: December 10, 2023; Revised: December 24, 2023; Accepted: December 27, 2023

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

The hypothalamus is part of the diencephalon and has several nuclei, one of which is the arcuate nucleus. The arcuate nucleus of hypothalamus (ARH) consists of neuroendocrine neurons and centrally-projecting neurons. The ARH is the center where the homeostasis of nutrition/metabolism and reproduction are maintained. As such, dysfunction of the ARH can lead to disorders of nutrition/metabolism and reproduction. Here, we review various types of neurons in the ARH and several genetic disorders caused by mutations in the ARH.

Graphical Abstract


Keywords: Arcuate nucleus, Hypothalamus, Metabolic disease, Central nervous system disease, Obesity

INTRODUCTION

The hypothalamus is a component of the diencephalon located inferior to the thalamus and superior to the midbrain. It serves as the highest regulator of the autonomic nervous system and plays a crucial role in maintaining glucose homeostasis and regulating the secretion of insulin, glucagon and various hormones. Although Claudius Galen in the second century and Andreas Vesalius in the 16th century described the brain region corresponding to the part of the hypothalamus, it was Wilhelm His who coined the term “hypothalamus” in 1893. The hypothalamus has several nuclei, which are aggregations of neurons: paraventricular nucleus (PVH), ventromedial nucleus (VMH), dorsomedial nucleus (DMH), preoptic nucleus, supraoptic nucleus, suprachiasmatic nucleus, lateral hypothalamic area (LHA) and arcuate nucleus. These hypothalamic nuclei are connected to each other and various surrounding brain regions, regulating the secretion of various peptides and neurotransmitters. The arcuate nucleus is also referred to as the infundibular nucleus or the arcuate nucleus of the hypothalamus (ARH) to distinguish it from another arcuate nucleus in the medulla oblongata (MO). The ARH was first described as nucleus infundibularis in 1948 by Hugo Spatz and colleagues, and is located in the mediobasal hypothalamus, adjacent to the third ventricle and the median eminence (ME) [1-4].

The ARH consists of various neurons that have diverse physiological roles ranging from cardiovascular regulation, feeding, energy expenditure, and fertility to metabolism. These neurons can be classified into two groups: neuroendocrine neurons and centrally-projecting neurons, which are not mutually exclusive. The neuroendocrine neurons release various neurotransmitters and/or neuropeptides, such as neuropeptide Y (NPY), agouti-related peptide (AgRP), cocaine- and amphetamine-regulated transcript (CART), dopamine, gonadotropin-releasing hormone (GnRH), growth hormone–releasing hormone (GHRH), kisspeptin (Kiss1), neurokinin B (NKB), dynorphin A, proopiomelanocortin (POMC) and substance P (SP). The centrally-projecting neurons transmit information to other hypothalamic nuclei or other brain regions outside the hypothalamus [2, 5-7].

This review describes the physiological and molecular functions and genetic disorders of various neurons in the ARH.

NEUROENDOCRINE NEURONS

NPY-expressing neurons

NPY, a 36-amino-acid orexigenic neuropeptide [8], was first identified from extracts of porcine brains without the cerebellum and pituitary gland by Tatemoto et al. [9]. In 1984, Clark and colleagues reported that intraventricular administration of NPY to ovariectomized rats pretreated with estradiol benzoate plus progesterone stimulated feeding behavior [10] (Table 1). Intraventricular infusion of NPY suppresses pulsatile GH release in rats [11-13]. However, genetic ablation of NPY in mice does not alter food intake and body weight, suggesting a functional redundancy of NPY [14, 15].

AgRP-expressing neurons

In 1997, the Barsh group showed that AgRP is a selective antagonist of the melanocortin receptors MC3R and MC4R and that transgenic mice expressing human AgRP develop obesity [16]. AgRP is an orexigenic peptide consisting of 132 amino acids – its mature form has 112 amino acids [17]. The Schwartz group demonstrated in 1998 that NPY and AgRP are co-expressed in fasting-activated ARH neurons [18]. ARH neurons expressing NPY/AgRP (ARHNPY/AgRP+) are GABAergic [19, 20]. They are activated by ghrelin [21, 22], and inactivated by leptin [19, 23], insulin, and glucose in the blood [24, 25], thus regulating energy balance and food intake [24-27]. Knockout of AgRP in mice show normal food intake and body weight, implying its functional redundancy [15], and have an extended life span with their point estimate of median survival exceeding that of their littermates by 9.8% [28].

Optogenetic activation of AgRP neurons in mice triggers voracious feeding within minutes [29]. In addition, chemical activation of these neurons in mice evoked food consumption, decreased energy expenditure, and enhanced fat stores [30]. Either ablation or suppression of ARHAgRP+ neurons causes aphagia [17, 30-32]. In vivo Ca2+ imaging using GCaMP6s has shown that sensory detection of food inhibits mice AgRP neurons very rapidly [33]. The Knight group showed that food intake stimulates mechanoreceptors in the intestinal vagal sensory neurons, which in turn inhibits ARHAgRP+ neurons [34]. The Horvath, Nitsch, and Vogt groups proposed that fasting evoked activation of ARHAgRP+ neurons elevates lysophosphatidic acid (LPA) species in the blood and cerebrospinal fluid, which subsequently elevates cortical excitability leading to hyperphagia [35]. The Anderman group showed that preemptive photostimulation of AgRP neurons in a home cage, but not in a threat-containing task arena, induces conditioned food seeking under threat [36].

CART-expressing neurons

The Douglass group identified in the rat brain an mRNA that was induced four- to fivefold by the administration of cocaine or amphetamine and named it CART in 1995. Human proCART has 89 amino acids. ARH neurons express CART [37], which functions as an anorexigenic peptide [38, 39]. Mice lacking CART exhibit an obesity phenotype [40, 41]. CART is also implicated in immunity, fluid balance, reproduction, learning and memory, sleep, stress, addiction and depression [42, 43]. G-protein coupled receptor (GPR) 160 was reported as a CART receptor [44, 45]. Single-cell RNA sequencing revealed that of three POMC clusters, ARHCART+ neurons overlap most abundantly with POMC/Anxa2 cluster neurons, yet showed little to no overlap with POMC/Ttr cluster and POMC/Glipr1 cluster neurons [46].

Dopamine-expressing neurons

In the 1960s and 1970s, dopamine released from tuberoinfundibular dopaminergic (TIDA) neurons in the ARH was reported to regulate prolactin secretion [47-50]. The Murakami group found that Neuromedin U inhibits prolactin secretion via activation of TIDA neurons [51]. Zufall, Leinders-Zufall and colleagues demonstrated that deletion of transient receptor potential (TRP) channel Trpc5 enhances dopamine release from TIDA neurons, which in turn causes hypoprolactinemia [52]. Approximately half of TIDA neurons are GABAergic and do not participate in the regulation of prolactin secretion [53].

Optogenetic activation of mouse ARH neurons expressing tyrosine hydroxylase (TH) suppresses POMC neurons and induces hyperphagia. TH is an enzyme that converts L-tyrosine to L-DOPA, a precursor of dopamine. Conversely, ablation of ARHTH+ neurons decreases body weight [54].

GnRH-expressing neurons

GnRH, a decaneuropeptide, stimulates the biosynthesis and release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary gland. The primary structure of mammalian GnRH was characterized in the early 1970s [55, 56]. In mammals, GnRH-expressing neurons originate in the developing olfactory pit, and migrate towards the hypothalamus, encompassing the primarily preoptic area and ARH, during early embryogenesis [57-59]. Estradiol feedback and Kiss1 modulate the excitability of ARHGnRH+ neurons [60]. ARH neurons that co-express Kiss1, NKB and dynorphin A (dubbed KNDy neurons) act in coordination to facilitate pulsatile secretion of GnRH, which is critical to reproductive endocrine function [61-64]. Mice carrying homozygous null GnRH mutation show hypogonadotropic hypogonadism [65-67].

GHRH-expressing neurons

GHRH, a 44-amino acid peptide hormone, binds to the its cognate receptor in the anterior pituitary gland, thereby stimulating the secretion of growth hormone (GH) [68-70]. The primary structure of human GHRH was elucidated in 1982 [71, 72]. In mammals, GHRH is synthesized in ARH neurons [73-75]. The knockout of GHRH in mice results in reduced body weight, increased insulin sensitivity and a prolonged lifespan compared to their littermates [76-78].

Kiss1-expressing neurons

Initially identified as a protein that suppresses the metastasis of human malignant melanoma [79], Kiss1 is synthesized in hypothalamic nuclei including the ARH [80]. Kiss1+ neurons exhibit electrophysiological properties characteristic of pacemaker neurons [81], and synthesize NKB and dynorphin as well [82]. Upon binding to its cognate receptor, GPR54 (also known as Kiss1 receptor [Kiss1R]), Kiss1 stimulates GnRH neurons triggering pulsatile GnRH release into the portal circulation. This induces the secretion of LH and FSH from the anterior pituitary gland [83-86]. Prolactin binds to prolactin receptors in ARHKiss+ neurons and thus decreases Kiss1 expression in female rats, leading to suppression of LH secretion and subsequent infertility [87].

Mice with a Kiss1 hypomorph mutation exhibit sexually dimorphic reproductive phenotypes: male mutants are fertile, whereas female mutants show impaired fertility and ovulation [88, 89]. The genetic ablation of Kiss1+ neurons results in fertile mice with smaller ovaries compared to their littermates, with no impact on the timing of female puberty onset [90]. ARH-specific deletion of Kiss1 leads to arrested folliculogenesis, hypogonadism and infertility in female mice, and hypogonadism, and variable, defective spermatogenesis, and subfertility in male mice [91]. Furthermore, ARHKiss1+ neurons are a necessary component of the hypothalamic circadian oscillator circuit [92].

NKB-expressing neurons

NKB, identified as a decaneuropeptide in 1983 [93-95], is generated through the proteolytic cleavage of a preproprotein encoded by TAC3. Its primary receptor is neurokinin 3 receptor (NK3R), also known as tachykinin receptor 3 (TACR3), which is a GPCR. TACR3 is not only found in the central nervous system (CNS), but also in the uterus, mesenteric vein, gut neurons, and placenta [96, 97]. Upon binding to NK3R, NKB stimulates GnRH neurons to release GnRH into the portal circulation [98].

Dynorphin A-expressing neurons

Dynorphin A is a potent opioid peptide consisting of 13 amino acids and its amino acid sequence was determined by the Avram Goldstein laboratory in 1981 [99, 100]. It activates the κ-opioid receptor (KOR), which is expressed throughout the brain and spinal cord [101], resulting in the modulation of pain, addiction and mood [102]. In mice lacking dynorphin, corticotropin releasing factor is unable to activate KOR in the basolateral amygdala, dorsal hippocampus and bed nucleus of the stria terminalis (BNST), all of which are brain regions associated with fear and anxiety [103, 104].

POMC-expressing neurons

Proteolytic cleavage of POMC results in the formation of various biologically active peptides including adrenocorticotropic hormone (ACTH), N-POMC, β–endorphin, α-, β– and γ-melanocyte-stimulating hormones (MSH). While POMC is primarily synthesized in the anterior pituitary, some ARH neurons also express POMC. Once secreted, POMC undergoes cleavage into α-MSH that binds to MC3/4R in the PVH neurons, thereby activating satiety signals [105-107]. POMC neurons regulate food intake and energy expenditure by responding to circulating blood glucose levels [108, 109]. Optogenetic activation of POMC neurons in mice has reduces food intake and body weight [29]. In vivo Ca2+ imaging using GCaMP6s revealed that food presentation to fasted mice activates POMC neurons very rapidly [33]. Glucagon-like peptide-1 (GLP-1) binds to the GLP-1 receptor in ARHPOMC+ neurons, thus suppressing food intake [110-112]. The Horvath group reported that activation of cannabinoid receptor 1 (CB1R) in the presynaptic terminals of POMC neurons triggers β–endorphin release and drives feeding [113]. The Yu group discovered that β–endorphin in the ARH contributes to antinociception in rats with inflammation [114]. The Low group observed that conditional knockout of POMC in the mouse ARH elicited hyperphagia, insulin resistance, obesity and improved glucose tolerance [115, 116].

SP-expressing neurons

SP was named by Gaddum and Schild [117] in 1934 and its 11-amino acid long sequence was determined in 1971 [118]. This neurokinin peptide is encoded by preprotachykinin A (PPTA or Tac1). PPTA also generates neurokinin A through alternate slicing [119]. SP is widely expressed in the brain including the ARH [120] and is implicated in nociception, respiration, inflammation, thermoregulation, the cardiovascular function and emotional and anxiety-related behaviors [121-123]. Glutamate induces SP release from the ARH and ME, thereby stimulating the secretion of gonadotropins [124]. The expression of SP and its receptor in the ARH peaks before mice puberty, and SP-/- mice exhibit delayed puberty and female subfertility [125].

CENTRALLY-PROJECTING NEURONS

The ARH receives signals from various sources, including hormonal and nutrient signals through the ME, afferent inputs from the vagus nerve and other brain nuclei, coordinates them and sends feedback responses via centrally-projecting neurons.

ARH neurons projecting to the PVH

ARH neurons expressing orexigenic (appetite-stimulating) peptides AgRP and NPY project to the PVH, where they bind to MC3/4R and NPY Y1 receptor (NPY1R), respectively. The binding of AgRP to MC3/4R, a receptor for α-MSH, suppresses the anorexigenic effect of α-MSH in the PVH [16]. In addition, the binding of NPY to NPY1R activates GABAergic neurons in the intermediate and parvicellular reticular nuclei of the MO possibly via the nucleus tractus solitarius (NTS) in the MO. This results in the stimulation of feeding behavior through the activation of the masticatory motor region and a decrease in energy expenditure via reduced sympathetic output to the brown adipose tissue (BAT) thermogenesis [51, 126-128].

Upon nutrient ingestion, ARH neurons expressing POMC (ARHPOMC+) that project to the PVH release α-MSH, activating MC4R on PVH neurons (Fig. 1). As a result, food intake is suppressed [129, 130]. ARH neurons expressing TH project to the PVH and the optogenetic activation of ARHTH+ axons releases both dopamine and GABA, thus inhibiting PVH neurons [54]. Projections from ARHAgRP/NPY+ to PVH can be remodeled both morphologically and functionally by fasting in mice [131].

ARH neurons projecting to the LHA

ARH neurons expressing both AgRP and NPY project to the LHA [132], and optogenetic stimulation of this projection can evoke feeding behavior in mice [133].

ARH neurons projecting to the DMH

ARHKiss1+ neurons project to DMH neurons. When activated optogenetically, they release glutamate, thus regulating energy expenditure in female mice [134]. Moreover, ARHNPY+ neurons project to DMH neurons expressing NPY1R. These in turn project to the nucleus raphe pallidus, resulting in the inhibition of sympathetic outputs for BAT thermogenesis, mean arterial pressure, and heart rate [127].

ARH neurons projecting to the anterior BNST (aBNST)

ARHAgRP+ neurons project to two distinct parts of the aBNST: the dorsomedial part (aBNSTdm) and the ventrolateral part (aBNSTvl). ARHAgRP+ projections to the aBNSTdm and aBNSTvl induce feeding and peripheral insulin resistance, respectively [133, 135].

ARH neurons projecting to the paraventricular thalamic nucleus (PVT)

ARHNPY+ and ARHCART+ neurons project to the PVT. As NPY and CART are orexigenic and anorexigenic, respectively, these two antagonistic circuits suggest that the PVT may integrate orexigenic and anorexigenic inputs [136].

ARH neurons projecting to the central nucleus of the amygdala (CEA)

The amygdala is involved in emotional responses including fear, anxiety, and aggression as well as the regulation of energy balance [137, 138]. Reciprocal projections exist between ARHNPY+/CART+ neurons and CEA neurons [24, 139]. Infusion of insulin into the CEA increases the immunoreactivity of c-Fos, a neuronal activity marker, in the ARH, suggesting that insulin mediates anorexia via this circuit [137, 140]. Alcohol activates ARHPOMC+ neurons projecting primarily to the amygdala, which may be implicated in rewarding effect responsible for alcohol use disorders [141].

ARH neurons projecting to the periaqueductal gray (PAG) in the midbrain

Retrograde labeling has revealed the projection of POMC neurons in the ARH to the PAG [142]. During electroacupuncture, glutamatergic reciprocal projections between ARH neurons and ventrolateral PAG neurons become activated [143]. Galanin activates projections from ARHβ–endorphin+ neurons to PAG neurons, thereby triggering anti-nociceptive effects [144].

ARH neurons projecting to the parabrachial nucleus (PBN)

ARH neurons co-expressing AgRP, NPY and GABA project to the PBN in the pons, thus inhibiting the GABAA receptor in neurons expressing calcitonin gene-related peptide (CGRP). This inhibition delays meal termination [145, 146].

ARH neurons projecting to the ventral tegmental area (VTA)

ARHPOMC+ neurons project to the VTA, inhibiting dopamine neurons in this region. In mice under chronic restraint stress, optogenetic inhibition of this circuit increases body weight and food intake, and suppresses depression-like behaviors and anhedonia [147].

ARH neurons projecting to the nucleus raphe obscurus

Optogenetic stimulation of aBNST neurons expressing glutamate decarboxylase 2 (aBNSTGad2+) in mice activates the nucleus raphe obscurus in the MO via projections from ARHGad2+ neurons, thereby mobilizing glucose rapidly [148].

ARH neurons projecting to the NTS

Activation of ARHGad2+ neurons through projections from aBNSTGad2+ neurons in mice stimulates projections to the NTS, eliciting anxiety-like behavior [148].

ARH neurons projecting to the nucleus accumbens (NAc)

ARHβ-endorphin+ neurons project to the GABAergic neurons in the NAc, which are associated with ethanol reinforcement [149, 150]. Chang et al. [151] demonstrated that acupuncture stimulates this projection and thus attenuates alcohol dependence in rats.

Projections from the PVHTRH/PACAP+ to the ARHAgRP+ neurons

PVH afferent neurons expressing thyrotropin-releasing hormone (TRH) and pituitary adenylate cyclase-activating polypeptide (PACAP), provide excitatory input to ARHAgRP+ neurons, thereby inducing intense feeding [152].

Projections from the ventral compartment of the DMH (vDMH) to the ARHAgRP+ neurons

In the fasted state, food detection rapidly activates GABAergic vDMHLepR/pDYN+ → ARHAgRP+ neurons, which in turn inhibit ARHAgRP+ neurons [153].

Projections from the NTS to the ARHPOMC+ neurons

GLP-1 neurons in the NTS project to ARHPOMC+ neurons expressing GLP-1R. This circuit is involved in the suppression of food intake [154].

ARH ASSOCIATED GENETIC DISEASES

Hypothalamic obesity syndrome (HOS)

Obesity, a chronic inflammation disorder, is associated with diverse diseases such as cardiovascular diseases, type 2 diabetes mellitus, certain types of cancer, and CNS diseases [155]. Characterized by overweight and disrupted energy homeostasis, obesity results from an imbalance between energy storage and expenditure, and excessive food intake [156]. The hypothalamus is the main brain region controlling energy homeostasis [157]. Specifically, neurons in the ARH including ARHAgRP/NPY+, ARHPOMC+ and ARHCART+ play a critical role in energy homeostasis [158]. In obese condition, hyperglycemia and insulin resistance can lead to hypothalamic inflammation, POMC neuronal loss and microglia activation in the ARH [159, 160]. While various factors including anatomic lesions, can caused HOS [161, 162], here we focus solely on genetic causes in the ARH.

Leptin, an anorexigenic hormone, is primarily produced in adipose cells and binds to its cognate receptor, the leptin receptor. This binding in AgRP/NPY neurons reduces expression and release of AgRP and NPY. However, this binding in CART/POMC neurons increases expression and release of CART and POMC. As a result, appetite reduction is suppressed, and locomotion, thermogenesis, and lipolysis are enhanced [163, 164]. Mutations in the leptin receptor are known to cause HOS [165, 166].

MC4R mutations negate the satiating effect of α-MSH in the ARH, and thus elicit hyperphagia and a higher satiety threshold. Once stimulated by leptin, ARHPOMC+ neurons produce α-MSH, which in turn binds to MC4R in PVH neurons. These mutations are the most common cause of monogenic obesity [167-170].

A heterozygous missense mutation in the CART gene (Leu34Phe) in ARHCART+ neurons is responsible for obesity with a reduced metabolic rate [171, 172].

Homozygous or compound heterozygous mutations in the POMC gene in ARHPOMC+ neurons cause early-onset obesity, hyperphagia, blunted satiety, secondary adrenal insufficiency, and pigmentary changes [173, 174].

Prohormone convertase 1 (PC1, also referred to as proprotein convertase subtilisin/kexin type 1 [PCSK1]) splices POMC in ARHPOMC+ neurons to liberate various biologically active peptides including ACTH and α-MSH. Compound heterozygous mutations in PC1 lead to early-onset obesity, hypoadrenalism, and reactive hypoglycemia [175, 176].

Age-related progressive weight gain typically develops in middle age, which is followed by anorexia (sarcopenia and/or cachexia) in old age. This phenomenon is primarily linked to a decrease and increase in ARHPOMC+ neuronal tone in middle age and old age, respectively [177-179].

Neurogenin 3 (Ngn3 or Neurog3) is a basic helix-loop-helix transcription factor implicated in the development of pancreatic β-cells and the hypothalamus. The conditional knockout of hypothalamic Ngn3 in mice elicits hyperphagia and reduced energy expenditure leading to obesity. This is primarily due to a decrease in the number of ARHPOMC+ neurons and an increase in the number of ARHNPY+ neurons [180, 181].

Nescient helix-loop-helix 2 (NHLH2) is a transcription factor that promotes the transcription of PC1/3 [182], and is a downstream target gene of leptin signaling [183]. Mutations in NHLH2 are associated with obesity [184-186].

Islet 1 (ISL1), a LIM-homeodomain transcription factor, augments expression of POMC, thereby promoting the terminal differentiation of ARHPOMC+ neurons in the developing hypothalamus. Conditional ISL1 knockout in mice ARHPOMC+ neurons induces hyperphagia and obesity [187, 188].

Tubby (Tub) is expressed in the human hypothalamus including the ARH and adipose tissue. Homozygous mutations in human Tub are associated with retinal dystrophy and early-onset obesity. However, the molecular function of Tub is still under debate [189, 190].

Orthopedia homeobox (Otp), a homeodomain transcription factor, is expressed in several hypothalamic nuclei including the ARH, and plays an important role in the development of hypothalamic neuroendocrine cell lineages in mice. Heterozygous missense mutations in Otp results in obesity, glucose intolerance and anxious behavior in mice [31, 191].

Given that obesity can ensue from various genetic mutations in the ARH neurons, investigation of genes associated with HOS followed by editing of a causative mutation(s) may offer a way to alleviate obesity.

Puberty and sexual maturation disorders

Homozygous or compound heterozygous mutations in Kiss1 or Kiss1R (also called GPR54) lead to hypogonadotropic hypogonadism, resulting in pubertal failure [85, 192-195]. Activating mutations in Kiss1 or Kiss1R cause central precocious puberty (CPP) [194, 196]. Mutations in NHLH2 also lead to hypogonadotropic hypogonadism [185, 186]. Furthermore, homozygous mutations in TAC3 or TACR3 elicit hypogonadotropic hypogonadism [197-200]. Loss-of-function mutations in the makorin ring finger protein 3 (MKRN3) and deletion mutations in the delta-like 1 homolog (DLK1) result in CPP [201, 202].

CONCLUSION

Various types of ARH neurons, their neuropeptides, and their projections play an important role in the regulation of nutrition/metabolism and reproduction. However, their precise roles remain unclear. Advanced manipulation of these neuropeptides and their cognate receptors in the ARH through genetics, optogenetics and chemogenetics could shed more light on the molecular mechanism by which the ARH regulates nutrition/metabolism and reproduction.

ACKNOWLEDGEMENTS

This work was supported by a grant from the Ministry of Science and ICT (MSIT)/National Research Foundation of Korea (NRF) (2021R1A2C2012951).

Figures

Fig. 1. Schematic illustration of projections to and from ARH neurons. aBNST, anterior bed nucleus of the stria terminalis; ARH, arcuate nucleus of hypothalamus; CEA, central nucleus of the amygdala; DMH, dorsomedial nucleus; LHA, lateral hypothalamic area; NAc, nucleus accumbens; NTS, nucleus tractus solitarius; PAG, periaqueductal gray; PBN, parabrachial nucleus; POMC, proopiomelanocortin; PVH, paraventricular nucleus; PVT, paraventricular thalamic nucleus; TRH, thyrotropin-releasing hormone; VTA, ventral tegmental area.

Tables

Table. 1.

Types of neurons in the ARH

Types of neuronsReferences numbers
Neuroendocrine neurons in ARHNPY-expressing neurons[8-10]
AgRP-expressing neurons[16-18]
CART-expressing neurons[37-39]
Dopamine-expressing neurons[47-50]
GnRH-expressing neurons[55-59]
GHRH-expressing neurons[68-75]
Kiss1-expressing neurons[79, 80, 82-86]
NKB-expressing neurons[93-98]
Dynorphin A-expressing neurons[99-102]
POMC-expressing neurons[105-109]
SP-expressing neurons[117-125]
Centrally-projecting neurons in ARHARH neurons projecting to the PVH[16, 51, 126-129]
ARH neurons projecting to the LHA[132, 133]
ARH neurons projecting to the DMH[127, 134]
ARH neurons projecting to the aBNST[133, 135]
ARH neurons projecting to the PVT[136]
ARH neurons projecting to the CEA[24, 137-139]
ARH neurons projecting to the PAG[142]
ARH neurons projecting to the PBN[145, 146]
ARH neurons projecting to the VTA[147]
ARH neurons projecting to the nucleus raphe obscurus[148]
ARH neurons projecting to the NTS[148]
ARH neurons projecting to the NAc[149-151]
Projections from the PVHTRH/PACAP+ to the ARHAgRP+ neurons[152]
Projections from the vDMH to the ARHAgRP+ neurons[153]
Projections from the NTS to the ARHPOMC+ neurons[154]

References

  1. Anderson E, Haymaker W (1974) Breakthroughs in hypothalamic and pituitary research. Prog Brain Res 41:1-60
    Pubmed CrossRef
  2. Chronwall BM (1985) Anatomy and physiology of the neuroendocrine arcuate nucleus. Peptides 6 Suppl 2:1-11
    Pubmed CrossRef
  3. Lechan RM, Toni R (2016) Functional anatomy of the hypothalamus and pituitary. In: Endotext (Feingold KR, Anawalt B, Blackman MR, ed(s)). MDText.com, Inc., South Dartmouth, MA
  4. Toni R, Malaguti A, Benfenati F, Martini L (2004) The human hypothalamus: a morpho-functional perspective. J Endocrinol Invest 27(6 Suppl):73-94
  5. Joly-Amado A, Cansell C, Denis RG, Delbes AS, Castel J, Martinez S, Luquet S (2014) The hypothalamic arcuate nucleus and the control of peripheral substrates. Best Pract Res Clin Endocrinol Metab 28:725-737
    Pubmed CrossRef
  6. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404:661-671
    Pubmed CrossRef
  7. Uwaifo GI (2021) The human hypothalamus: anatomy, dysfunction and disease management. Humana, Cham
    CrossRef
  8. Timper K, Brüning JC (2017) Hypothalamic circuits regulating appetite and energy homeostasis: pathways to obesity. Dis Model Mech 10:679-689
    Pubmed KoreaMed CrossRef
  9. Tatemoto K, Carlquist M, Mutt V (1982) Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296:659-660
    Pubmed CrossRef
  10. Clark JT, Kalra PS, Crowley WR, Kalra SP (1984) Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115:427-429
    Pubmed CrossRef
  11. Pierroz DD, Catzeflis C, Aebi AC, Rivier JE, Aubert ML (1996) Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats. Endocrinology 137:3-12
    Pubmed CrossRef
  12. Sainsbury A, Herzog H (2001) Inhibitory effects of central neuropeptide Y on the somatotropic and gonadotropic axes in male rats are independent of adrenal hormones. Peptides 22:467-471
    Pubmed CrossRef
  13. Suzuki N, Okada K, Minami S, Wakabayashi I (1996) Inhibitory effect of neuropeptide Y on growth hormone secretion in rats is mediated by both Y1- and Y2-receptor subtypes and abolished after anterolateral deafferentation of the medial basal hypothalamus. Regul Pept 65:145-151
    Pubmed CrossRef
  14. Erickson JC, Clegg KE, Palmiter RD (1996) Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381:415-421
    Pubmed CrossRef
  15. Qian S, Chen H, Weingarth D, Trumbauer ME, Novi DE, Guan X, Yu H, Shen Z, Feng Y, Frazier E, Chen A, Camacho RE, Shearman LP, Gopal-Truter S, MacNeil DJ, Van der Ploeg LH, Marsh DJ (2002) Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol Cell Biol 22:5027-5035
    Pubmed KoreaMed CrossRef
  16. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, Barsh GS (1997) Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278:135-138
    Pubmed CrossRef
  17. Gropp E, Shanabrough M, Borok E, Xu AW, Janoschek R, Buch T, Plum L, Balthasar N, Hampel B, Waisman A, Barsh GS, Horvath TL, Brüning JC (2005) Agouti-related peptide-expressing neurons are mandatory for feeding. Nat Neurosci 8:1289-1291
    Pubmed CrossRef
  18. Hahn TM, Breininger JF, Baskin DG, Schwartz MW (1998) Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat Neurosci 1:271-272
    Pubmed CrossRef
  19. Cowley MA, Smart JL, Rubinstein M, Cerdán MG, Diano S, Horvath TL, Cone RD, Low MJ (2001) Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411:480-484
    Pubmed CrossRef
  20. Horvath TL, Bechmann I, Naftolin F, Kalra SP, Leranth C (1997) Heterogeneity in the neuropeptide Y-containing neurons of the rat arcuate nucleus: GABAergic and non-GABAergic subpopulations. Brain Res 756:283-286
    Pubmed CrossRef
  21. Cowley MA, Smith RG, Diano S, Tschöp M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu H, Pinto S, Colmers WF, Cone RD, Horvath TL (2003) The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37:649-661
    Pubmed CrossRef
  22. Kohno D, Gao HZ, Muroya S, Kikuyama S, Yada T (2003) Ghrelin directly interacts with neuropeptide-Y-containing neurons in the rat arcuate nucleus: Ca2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes 52:948-956
    Pubmed CrossRef
  23. Kohno D, Nakata M, Maekawa F, Fujiwara K, Maejima Y, Kuramochi M, Shimazaki T, Okano H, Onaka T, Yada T (2007) Leptin suppresses ghrelin-induced activation of neuropeptide Y neurons in the arcuate nucleus via phosphatidylinositol 3-kinase- and phosphodiesterase 3-mediated pathway. Endocrinology 148:2251-2263
    Pubmed CrossRef
  24. Mitchell CS, Begg DP (2021) The regulation of food intake by insulin in the central nervous system. J Neuroendocrinol 33:e12952
    Pubmed CrossRef
  25. Vohra MS, Benchoula K, Serpell CJ, Hwa WE (2022) AgRP/NPY and POMC neurons in the arcuate nucleus and their potential role in treatment of obesity. Eur J Pharmacol 915:174611
    Pubmed CrossRef
  26. Goldstein N, McKnight AD, Carty JRE, Arnold M, Betley JN, Alhadeff AL (2021) Hypothalamic detection of macronutrients via multiple gut-brain pathways. Cell Metab 33:676-687.e5
    Pubmed KoreaMed CrossRef
  27. Morselli LL, Claflin KE, Cui H, Grobe JL (2018) Control of energy expenditure by AgRP neurons of the arcuate nucleus: neurocircuitry, signaling pathways, and angiotensin. Curr Hypertens Rep 20:25
    Pubmed KoreaMed CrossRef
  28. Redmann SM Jr, Argyropoulos G (2006) AgRP-deficiency could lead to increased lifespan. Biochem Biophys Res Commun 351:860-864
    Pubmed KoreaMed CrossRef
  29. Aponte Y, Atasoy D, Sternson SM (2011) AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training. Nat Neurosci 14:351-355
    Pubmed KoreaMed CrossRef
  30. Krashes MJ, Koda S, Ye C, Rogan SC, Adams AC, Cusher DS, Maratos-Flier E, Roth BL, Lowell BB (2011) Rapid, reversible activation of AgRP neurons drives feeding behavior in mice. J Clin Invest 121:1424-1428
    Pubmed KoreaMed CrossRef
  31. Acampora D, Postiglione MP, Avantaggiato V, Di Bonito M, Vaccarino FM, Michaud J, Simeone A (1999) Progressive impairment of developing neuroendocrine cell lineages in the hypothalamus of mice lacking the Orthopedia gene. Genes Dev 13:2787-2800
    Pubmed KoreaMed CrossRef
  32. Luquet S, Perez FA, Hnasko TS, Palmiter RD (2005) NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 310:683-685
    Pubmed CrossRef
  33. Chen Y, Lin YC, Kuo TW, Knight ZA (2015) Sensory detection of food rapidly modulates arcuate feeding circuits. Cell 160:829-841
    Pubmed KoreaMed CrossRef
  34. Bai L, Mesgarzadeh S, Ramesh KS, Huey EL, Liu Y, Gray LA, Aitken TJ, Chen Y, Beutler LR, Ahn JS, Madisen L, Zeng H, Krasnow MA, Knight ZA (2019) Genetic identification of vagal sensory neurons that control feeding. Cell 179:1129-1143.e23
    Pubmed KoreaMed CrossRef
  35. Endle H, Horta G, Stutz B, Muthuraman M, Tegeder I, Schreiber Y, Snodgrass IF, Gurke R, Liu ZW, Sestan-Pesa M, Radyushkin K, Streu N, Fan W, Baumgart J, Li Y, Kloss F, Groppa S, Opel N, Dannlowski U, Grabe HJ, Zipp F, Rácz B, Horvath TL, Nitsch R, Vogt J (2022) AgRP neurons control feeding behaviour at cortical synapses via peripherally derived lysophospholipids. Nat Metab 4:683-692
    Pubmed KoreaMed CrossRef
  36. Jikomes N, Ramesh RN, Mandelblat-Cerf Y, Andermann ML (2016) Preemptive stimulation of AgRP neurons in fed mice enables conditioned food seeking under threat. Curr Biol 26:2500-2507
    Pubmed KoreaMed CrossRef
  37. Douglass J, McKinzie AA, Couceyro P (1995) PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J Neurosci 15(3 Pt 2):2471-2481
    Pubmed KoreaMed CrossRef
  38. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, Larsen PJ, Hastrup S (1998) Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393:72-76
    Pubmed CrossRef
  39. Lau J, Farzi A, Qi Y, Heilbronn R, Mietzsch M, Shi YC, Herzog H (2018) CART neurons in the arcuate nucleus and lateral hypothalamic area exert differential controls on energy homeostasis. Mol Metab 7:102-118
    Pubmed KoreaMed CrossRef
  40. Asnicar MA, Smith DP, Yang DD, Heiman ML, Fox N, Chen YF, Hsiung HM, Köster A (2001) Absence of cocaine- and amphetamine-regulated transcript results in obesity in mice fed a high caloric diet. Endocrinology 142:4394-4400
    Pubmed CrossRef
  41. Wierup N, Richards WG, Bannon AW, Kuhar MJ, Ahrén B, Sundler F (2005) CART knock out mice have impaired insulin secretion and glucose intolerance, altered beta cell morphology and increased body weight. Regul Pept 129:203-211
    Pubmed CrossRef
  42. Lau J, Herzog H (2014) CART in the regulation of appetite and energy homeostasis. Front Neurosci 8:313
    Pubmed KoreaMed CrossRef
  43. Singh A, de Araujo AM, Krieger JP, Vergara M, Ip CK, de Lartigue G (2021) Demystifying functional role of cocaine- and amphetamine-related transcript (CART) peptide in control of energy homeostasis: a twenty-five year expedition. Peptides 140:170534
    Pubmed KoreaMed CrossRef
  44. Haddock CJ, Almeida-Pereira G, Stein LM, Hayes MR, Kolar GR, Samson WK, Yosten GLC (2021) Signaling in rat brainstem via Gpr160 is required for the anorexigenic and antidipsogenic actions of cocaine- and amphetamine-regulated transcript peptide. Am J Physiol Regul Integr Comp Physiol 320:R236-R249
    Pubmed KoreaMed CrossRef
  45. Yosten GL, Harada CM, Haddock C, Giancotti LA, Kolar GR, Patel R, Guo C, Chen Z, Zhang J, Doyle TM, Dickenson AH, Samson WK, Salvemini D (2020) GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents. J Clin Invest 130:2587-2592
    Pubmed KoreaMed CrossRef
  46. Campbell JN, Macosko EZ, Fenselau H, Pers TH, Lyubetskaya A, Tenen D, Goldman M, Verstegen AM, Resch JM, McCarroll SA, Rosen ED, Lowell BB, Tsai LT (2017) A molecular census of arcuate hypothalamus and median eminence cell types. Nat Neurosci 20:484-496
    Pubmed KoreaMed CrossRef
  47. Birge CA, Jacobs LS, Hammer CT, Daughaday WH (1970) Catecholamine inhibition of prolactin secretion by isolated rat adenohypophyses. Endocrinology 86:120-130
    Pubmed CrossRef
  48. Björklund A, Moore RY, Nobin A, Stenevi U (1973) The organization of tubero-hypophyseal and reticulo-infundibular catecholamine neuron systems in the rat brain. Brain Res 51:171-191
    Pubmed CrossRef
  49. Dahlstroem A, Fuxe K (1964) Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol Scand Suppl Suppl 232:1-55
  50. MacLeod RM, Fontham EH, Lehmeyer JE (1970) Prolactin and growth hormone production as influenced by catecholamines and agents that affect brain catecholamines. Neuroendocrinology 6:283-294
    Pubmed CrossRef
  51. Nakamura Y, Yanagawa Y, Morrison SF, Nakamura K (2017) Medullary reticular neurons mediate neuropeptide Y-induced metabolic inhibition and mastication. Cell Metab 25:322-334
    Pubmed KoreaMed CrossRef
  52. Blum T, Moreno-Pérez A, Pyrski M, Bufe B, Arifovic A, Weissgerber P, Freichel M, Zufall F, Leinders-Zufall T (2019) Trpc5 deficiency causes hypoprolactinemia and altered function of oscillatory dopamine neurons in the arcuate nucleus. Proc Natl Acad Sci U S A 116:15236-15243
    Pubmed KoreaMed CrossRef
  53. Brown RS, Kokay IC, Phillipps HR, Yip SH, Gustafson P, Wyatt A, Larsen CM, Knowles P, Ladyman SR, LeTissier P, Grattan DR (2016) Conditional deletion of the prolactin receptor reveals functional subpopulations of dopamine neurons in the arcuate nucleus of the hypothalamus. J Neurosci 36:9173-9185
    Pubmed KoreaMed CrossRef
  54. Zhang X, van den Pol AN (2016) Hypothalamic arcuate nucleus tyrosine hydroxylase neurons play orexigenic role in energy homeostasis. Nat Neurosci 19:1341-1347
    Pubmed KoreaMed CrossRef
  55. Burgus R, Butcher M, Amoss M, Ling N, Monahan M, Rivier J, Fellows R, Blackwell R, Vale W, Guillemin R (1972) Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF) (LH-hypothalamus-LRF-gas chromatography-mass spectrometry-decapeptide-Edman degradation). Proc Natl Acad Sci U S A 69:278-282
    Pubmed KoreaMed CrossRef
  56. Matsuo H, Baba Y, Nair RM, Arimura A, Schally AV (1971) Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence. Biochem Biophys Res Commun 43:1334-1339
    Pubmed CrossRef
  57. Schwanzel-Fukuda M, Pfaff DW (1989) Origin of luteinizing hormone-releasing hormone neurons. Nature 338:161-164
    Pubmed CrossRef
  58. Wray S, Grant P, Gainer H (1989) Evidence that cells expressing luteinizing hormone-releasing hormone mRNA in the mouse are derived from progenitor cells in the olfactory placode. Proc Natl Acad Sci U S A 86:8132-8136
    Pubmed KoreaMed CrossRef
  59. Wray S, Nieburgs A, Elkabes S (1989) Spatiotemporal cell expression of luteinizing hormone-releasing hormone in the prenatal mouse: evidence for an embryonic origin in the olfactory placode. Brain Res Dev Brain Res 46:309-318
    Pubmed CrossRef
  60. Adams C, Stroberg W, DeFazio RA, Schnell S, Moenter SM (2018) Gonadotropin-releasing hormone (GnRH) neuron excitability is regulated by estradiol feedback and kisspeptin. J Neurosci 38:1249-1263
    Pubmed KoreaMed CrossRef
  61. Clarkson J, Han SY, Piet R, McLennan T, Kane GM, Ng J, Porteous RW, Kim JS, Colledge WH, Iremonger KJ, Herbison AE (2017) Definition of the hypothalamic GnRH pulse generator in mice. Proc Natl Acad Sci U S A 114:E10216-E10223
    Pubmed KoreaMed CrossRef
  62. Goodman RL, Lehman MN, Smith JT, Coolen LM, de Oliveira CV, Jafarzadehshirazi MR, Pereira A, Iqbal J, Caraty A, Ciofi P, Clarke IJ (2007) Kisspeptin neurons in the arcuate nucleus of the ewe express both dynorphin A and neurokinin B. Endocrinology 148:5752-5760
    Pubmed CrossRef
  63. Han SY, McLennan T, Czieselsky K, Herbison AE (2015) Selective optogenetic activation of arcuate kisspeptin neurons generates pulsatile luteinizing hormone secretion. Proc Natl Acad Sci U S A 112:13109-13114
    Pubmed KoreaMed CrossRef
  64. Plant TM (2019) The neurobiological mechanism underlying hypothalamic GnRH pulse generation: the role of kisspeptin neurons in the arcuate nucleus F1000Res 8:F1000 Faculty Rev-982
    KoreaMed CrossRef
  65. Adelman JP, Mason AJ, Hayflick JS, Seeburg PH (1986) Isolation of the gene and hypothalamic cDNA for the common precursor of gonadotropin-releasing hormone and prolactin release-inhibiting factor in human and rat. Proc Natl Acad Sci U S A 83:179-183
    Pubmed KoreaMed CrossRef
  66. Cattanach BM, Iddon CA, Charlton HM, Chiappa SA, Fink G (1977) Gonadotrophin-releasing hormone deficiency in a mutant mouse with hypogonadism. Nature 269:338-340
    Pubmed CrossRef
  67. Mason AJ, Hayflick JS, Zoeller RT, Young WS 3rd, Phillips HS, Nikolics K, Seeburg PH (1986) A deletion truncating the gonadotropin-releasing hormone gene is responsible for hypogonadism in the hpg mouse. Science 234:1366-1371
    Pubmed CrossRef
  68. Frohman LA, Szabo M (1981) Ectopic production of growth hormone-releasing factor by carcinoid and pancreatic islet tumors associated with acromegaly. Prog Clin Biol Res 74:259-271
  69. Gaylinn BD (1999) Molecular and cell biology of the growth hormone-releasing hormone receptor. Growth Horm IGF Res 9 Suppl A:37-44
    Pubmed CrossRef
  70. Reichlin S (1961) Growth hormone content of pituitaries from rats with hypothalamic lesions. Endocrinology 69:225-230
    Pubmed CrossRef
  71. Guillemin R, Brazeau P, Böhlen P, Esch F, Ling N, Wehrenberg WB (1982) Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science 218:585-587
    Pubmed CrossRef
  72. Rivier J, Spiess J, Thorner M, Vale W (1982) Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature 300:276-278
    Pubmed CrossRef
  73. Bloch B, Gaillard RC, Brazeau P, Lin HD, Ling N (1984) Topographical and ontogenetic study of the neurons producing growth hormone-releasing factor in human hypothalamus. Regul Pept 8:21-31
    Pubmed CrossRef
  74. Frohman LA, Jansson JO (1986) Growth hormone-releasing hormone. Endocr Rev 7:223-253
    Pubmed CrossRef
  75. Frohman LA, Nernardis LL, Kant KJ (1968) Hypothalamic stimulation of growth hormone secretion. Science 162:580-582
    Pubmed CrossRef
  76. Alba M, Salvatori R (2004) A mouse with targeted ablation of the growth hormone-releasing hormone gene: a new model of isolated growth hormone deficiency. Endocrinology 145:4134-4143
    Pubmed CrossRef
  77. Icyuz M, Fitch M, Zhang F, Challa A, Sun LY (2020) Physiological and metabolic features of mice with CRISPR/Cas9-mediated loss-of-function in growth hormone-releasing hormone. Aging (Albany NY) 12:9761-9780
    Pubmed KoreaMed CrossRef
  78. Sun LY, Spong A, Swindell WR, Fang Y, Hill C, Huber JA, Boehm JD, Westbrook R, Salvatori R, Bartke A (2013) Growth hormone-releasing hormone disruption extends lifespan and regulates response to caloric restriction in mice. Elife 2:e01098
    CrossRef
  79. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, Welch DR (1996) KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 88:1731-1737
    Pubmed CrossRef
  80. Clarkson J, Herbison AE (2006) Postnatal development of kisspeptin neurons in mouse hypothalamus; sexual dimorphism and projections to gonadotropin-releasing hormone neurons. Endocrinology 147:5817-5825
    Pubmed KoreaMed CrossRef
  81. Gottsch ML, Popa SM, Lawhorn JK, Qiu J, Tonsfeldt KJ, Bosch MA, Kelly MJ, Rønnekleiv OK, Sanz E, McKnight GS, Clifton DK, Palmiter RD, Steiner RA (2011) Molecular properties of Kiss1 neurons in the arcuate nucleus of the mouse. Endocrinology 152:4298-4309
    Pubmed KoreaMed CrossRef
  82. Lehman MN, Coolen LM, Goodman RL (2010) Minireview: kisspeptin/neurokinin B/dynorphin (KNDy) cells of the arcuate nucleus: a central node in the control of gonadotropin-releasing hormone secretion. Endocrinology 151:3479-3489
    Pubmed KoreaMed CrossRef
  83. Muir AI, Chamberlain L, Elshourbagy NA, Michalovich D, Moore DJ, Calamari A, Szekeres PG, Sarau HM, Chambers JK, Murdock P, Steplewski K, Shabon U, Miller JE, Middleton SE, Darker JG, Larminie CG, Wilson S, Bergsma DJ, Emson P, Faull R, Philpott KL, Harrison DC (2001) AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem 276:28969-28975
    Pubmed CrossRef
  84. Novaira HJ, Ng Y, Wolfe A, Radovick S (2009) Kisspeptin increases GnRH mRNA expression and secretion in GnRH secreting neuronal cell lines. Mol Cell Endocrinol 311:126-134
    Pubmed KoreaMed CrossRef
  85. Skorupskaite K, George JT, Anderson RA (2014) The kisspeptin-GnRH pathway in human reproductive health and disease. Hum Reprod Update 20:485-500
    Pubmed KoreaMed CrossRef
  86. Thompson EL, Patterson M, Murphy KG, Smith KL, Dhillo WS, Todd JF, Ghatei MA, Bloom SR (2004) Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis. J Neuroendocrinol 16:850-858
    Pubmed CrossRef
  87. Araujo-Lopes R, Crampton JR, Aquino NS, Miranda RM, Kokay IC, Reis AM, Franci CR, Grattan DR, Szawka RE (2014) Prolactin regulates kisspeptin neurons in the arcuate nucleus to suppress LH secretion in female rats. Endocrinology 155:1010-1020
    Pubmed CrossRef
  88. Kavanagh GS, Tadi J, Balkenhol SM, Kauffman AS, Maloney SK, Smith JT (2022) Kisspeptin impacts on circadian and ultradian rhythms of core body temperature: evidence in kisspeptin receptor knockout and kisspeptin knockdown mice. Mol Cell Endocrinol 542:111530
    Pubmed KoreaMed CrossRef
  89. Popa SM, Moriyama RM, Caligioni CS, Yang JJ, Cho CM, Concepcion TL, Oakley AE, Lee IH, Sanz E, Amieux PS, Caraty A, Palmiter RD, Navarro VM, Chan YM, Seminara SB, Clifton DK, Steiner RA (2013) Redundancy in Kiss1 expression safeguards reproduction in the mouse. Endocrinology 154:2784-2794
    Pubmed KoreaMed CrossRef
  90. Mayer C, Boehm U (2011) Female reproductive maturation in the absence of kisspeptin/GPR54 signaling. Nat Neurosci 14:704-710
    Pubmed CrossRef
  91. Nandankar N, Negrón AL, Wolfe A, Levine JE, Radovick S (2021) Deficiency of arcuate nucleus kisspeptin results in postpubertal central hypogonadism. Am J Physiol Endocrinol Metab 321:E264-E280
    Pubmed KoreaMed CrossRef
  92. Padilla SL, Perez JG, Ben-Hamo M, Johnson CW, Sanchez REA, Bussi IL, Palmiter RD, de la Iglesia HO (2019) Kisspeptin neurons in the arcuate nucleus of the hypothalamus orchestrate circadian rhythms and metabolism. Curr Biol 29:592-604.e4
    Pubmed KoreaMed CrossRef
  93. Kangawa K, Minamino N, Fukuda A, Matsuo H (1983) Neuromedin K: a novel mammalian tachykinin identified in porcine spinal cord. Biochem Biophys Res Commun 114:533-540
    Pubmed CrossRef
  94. Maggio JE (1988) Tachykinins. Annu Rev Neurosci 11:13-28
    Pubmed CrossRef
  95. Nawa H, Hirose T, Takashima H, Inayama S, Nakanishi S (1983) Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursor. Nature 306:32-36
    Pubmed CrossRef
  96. Buell G, Schulz MF, Arkinstall SJ, Maury K, Missotten M, Adami N, Talabot F, Kawashima E (1992) Molecular characterisation, expression and localisation of human neurokinin-3 receptor. FEBS Lett 299:90-95
    Pubmed CrossRef
  97. Huang RR, Cheung AH, Mazina KE, Strader CD, Fong TM (1992) cDNA sequence and heterologous expression of the human neurokinin-3 receptor. Biochem Biophys Res Commun 184:966-972
    Pubmed CrossRef
  98. Ramaswamy S, Seminara SB, Ali B, Ciofi P, Amin NA, Plant TM (2010) Neurokinin B stimulates GnRH release in the male monkey (Macaca mulatta) and is colocalized with kisspeptin in the arcuate nucleus. Endocrinology 151:4494-4503
    Pubmed KoreaMed CrossRef
  99. Chavkin C (2013) Dynorphin--still an extraordinarily potent opioid peptide. Mol Pharmacol 83:729-736
    Pubmed KoreaMed CrossRef
  100. Goldstein A, Fischli W, Lowney LI, Hunkapiller M, Hood L (1981) Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide. Proc Natl Acad Sci U S A 78:7219-7223
    Pubmed KoreaMed CrossRef
  101. Wagner JJ, Evans CJ, Chavkin C (1991) Focal stimulation of the mossy fibers releases endogenous dynorphins that bind kappa 1-opioid receptors in guinea pig hippocampus. J Neurochem 57:333-343
    Pubmed CrossRef
  102. Ferré G, Czaplicki G, Demange P, Milon A (2019) Structure and dynamics of dynorphin peptide and its receptor. Vitam Horm 111:17-47
    Pubmed CrossRef
  103. Knoll AT, Carlezon WA Jr (2010) Dynorphin, stress, and depression. Brain Res 1314:56-73
    Pubmed KoreaMed CrossRef
  104. Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C (2008) The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J Neurosci 28:407-414
    Pubmed KoreaMed CrossRef
  105. Cawley NX, Li Z, Loh YP (2016) 60 Years of POMC: biosynthesis, trafficking, and secretion of pro-opiomelanocortin-derived peptides. J Mol Endocrinol 56:T77-T97
    Pubmed KoreaMed CrossRef
  106. Cone RD (2005) Anatomy and regulation of the central melanocortin system. Nat Neurosci 8:571-578
    Pubmed CrossRef
  107. Toda C, Santoro A, Kim JD, Diano S (2017) POMC neurons: from birth to death. Annu Rev Physiol 79:209-236
    Pubmed KoreaMed CrossRef
  108. Levin BE, Routh VH, Kang L, Sanders NM, Dunn-Meynell AA (2004) Neuronal glucosensing: what do we know after 50 years?. Diabetes 53:2521-2528
    Pubmed CrossRef
  109. Parton LE, Ye CP, Coppari R, Enriori PJ, Choi B, Zhang CY, Xu C, Vianna CR, Balthasar N, Lee CE, Elmquist JK, Cowley MA, Lowell BB (2007) Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 449:228-232
    Pubmed CrossRef
  110. Biglari N, Gaziano I, Schumacher J, Radermacher J, Paeger L, Klemm P, Chen W, Corneliussen S, Wunderlich CM, Sue M, Vollmar S, Klöckener T, Sotelo-Hitschfeld T, Abbasloo A, Edenhofer F, Reimann F, Gribble FM, Fenselau H, Kloppenburg P, Wunderlich FT, Brüning JC (2021) Functionally distinct POMC-expressing neuron subpopulations in hypothalamus revealed by intersectional targeting. Nat Neurosci 24:913-929
    Pubmed KoreaMed CrossRef
  111. Gabery S, Salinas CG, Paulsen SJ, Ahnfelt-Rønne J, Alanentalo T, Baquero AF, Buckley ST, Farkas E, Fekete C, Frederiksen KS, Helms HCC, Jeppesen JF, John LM, Pyke C, Nøhr J, Lu TT, Polex-Wolf J, Prevot V, Raun K, Simonsen L, Sun G, Szilvásy-Szabó A, Willenbrock H, Secher A, Knudsen LB, Hogendorf WFJ (2020) Semaglutide lowers body weight in rodents via distributed neural pathways. JCI Insight 5:e133429
    Pubmed KoreaMed CrossRef
  112. Secher A, Jelsing J, Baquero AF, Hecksher-Sørensen J, Cowley MA, Dalbøge LS, Hansen G, Grove KL, Pyke C, Raun K, Schäffer L, Tang-Christensen M, Verma S, Witgen BM, Vrang N, Bjerre Knudsen L (2014) The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss. J Clin Invest 124:4473-4488
    Pubmed KoreaMed CrossRef
  113. Koch M, Varela L, Kim JG, Kim JD, Hernández-Nuño F, Simonds SE, Castorena CM, Vianna CR, Elmquist JK, Morozov YM, Rakic P, Bechmann I, Cowley MA, Szigeti-Buck K, Dietrich MO, Gao XB, Diano S, Horvath TL (2015) Hypothalamic POMC neurons promote cannabinoid-induced feeding. Nature 519:45-50
    Pubmed KoreaMed CrossRef
  114. Sun YG, Lundeberg T, Yu LC (2003) Involvement of endogenous beta-endorphin in antinociception in the arcuate nucleus of hypothalamus in rats with inflammation. Pain 104:55-63
    Pubmed CrossRef
  115. Bumaschny VF, Yamashita M, Casas-Cordero R, Otero-Corchón V, de Souza FS, Rubinstein M, Low MJ (2012) Obesity-programmed mice are rescued by early genetic intervention. J Clin Invest 122:4203-4212
    Pubmed KoreaMed CrossRef
  116. Chhabra KH, Adams JM, Fagel B, Lam DD, Qi N, Rubinstein M, Low MJ (2016) Hypothalamic POMC deficiency improves glucose tolerance despite insulin resistance by increasing glycosuria. Diabetes 65:660-672
    Pubmed KoreaMed CrossRef
  117. Gaddum JH, Schild H (1934) Depressor substances in extracts of intestine. J Physiol 83:1-14
    Pubmed KoreaMed CrossRef
  118. Chang MM, Leeman SE, Niall HD (1971) Amino-acid sequence of Substance P. Nat New Biol 232:86-87
    Pubmed CrossRef
  119. Harmar AJ, Hyde V, Chapman K (1990) Identification and cDNA sequence of delta-preprotachykinin, a fourth splicing variant of the rat Substance P precursor. FEBS Lett 275:22-24
    Pubmed CrossRef
  120. Ribeiro-da-Silva A, Hökfelt T (2000) Neuroanatomical localisation of Substance P in the CNS and sensory neurons. Neuropeptides 34:256-271
    Pubmed CrossRef
  121. Harrison S, Geppetti P (2001) Substance P. Int J Biochem Cell Biol 33:555-576
    Pubmed CrossRef
  122. Otsuka M, Yoshioka K (1993) Neurotransmitter functions of mammalian tachykinins. Physiol Rev 73:229-308
    Pubmed CrossRef
  123. Severini C, Improta G, Falconieri-Erspamer G, Salvadori S, Erspamer V (2002) The tachykinin peptide family. Pharmacol Rev 54:285-322
    Pubmed CrossRef
  124. Caruso C, Durand D, Watanobe H, Lasaga M (2006) NMDA and group I metabotropic glutamate receptors activation modulates Substance P release from the arcuate nucleus and median eminence. Neurosci Lett 393:60-64
    Pubmed CrossRef
  125. Simavli S, Thompson IR, Maguire CA, Gill JC, Carroll RS, Wolfe A, Kaiser UB, Navarro VM (2015) Substance P regulates puberty onset and fertility in the female mouse. Endocrinology 156:2313-2322
    Pubmed KoreaMed CrossRef
  126. Shi YC, Lau J, Lin Z, Zhang H, Zhai L, Sperk G, Heilbronn R, Mietzsch M, Weger S, Huang XF, Enriquez RF, Baldock PA, Zhang L, Sainsbury A, Herzog H, Lin S (2013) Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN. Cell Metab 17:236-248
    Pubmed CrossRef
  127. Shi Z, Bonillas AC, Wong J, Padilla SL, Brooks VL (2021) Neuropeptide Y suppresses thermogenic and cardiovascular sympathetic nerve activity via Y1 receptors in the paraventricular nucleus and dorsomedial hypothalamus. J Neuroendocrinol 33:e13006
    Pubmed KoreaMed CrossRef
  128. Yokosuka M, Kalra PS, Kalra SP (1999) Inhibition of neuropeptide Y (NPY)-induced feeding and c-Fos response in magnocellular paraventricular nucleus by a NPY receptor antagonist: a site of NPY action. Endocrinology 140:4494-4500
    Pubmed CrossRef
  129. Balthasar N, Dalgaard LT, Lee CE, Yu J, Funahashi H, Williams T, Ferreira M, Tang V, McGovern RA, Kenny CD, Christiansen LM, Edelstein E, Choi B, Boss O, Aschkenasi C, Zhang CY, Mountjoy K, Kishi T, Elmquist JK, Lowell BB (2005) Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 123:493-505
    Pubmed CrossRef
  130. Bouret SG, Draper SJ, Simerly RB (2004) Formation of projection pathways from the arcuate nucleus of the hypothalamus to hypothalamic regions implicated in the neural control of feeding behavior in mice. J Neurosci 24:2797-2805
    Pubmed KoreaMed CrossRef
  131. Cabral A, Fernandez G, Tolosa MJ, Rey Moggia Á, Calfa G, De Francesco PN, Perello M (2020) Fasting induces remodeling of the orexigenic projections from the arcuate nucleus to the hypothalamic paraventricular nucleus, in a growth hormone secretagogue receptor-dependent manner. Mol Metab 32:69-84
    Pubmed KoreaMed CrossRef
  132. Broberger C, De Lecea L, Sutcliffe JG, Hökfelt T (1998) Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol 402:460-474
    CrossRef
  133. Betley JN, Cao ZF, Ritola KD, Sternson SM (2013) Parallel, redundant circuit organization for homeostatic control of feeding behavior. Cell 155:1337-1350
    Pubmed KoreaMed CrossRef
  134. Stincic TL, Qiu J, Connors AM, Kelly MJ, Rønnekleiv OK (2021) Arcuate and preoptic kisspeptin neurons exhibit differential projections to hypothalamic nuclei and exert opposite postsynaptic effects on hypothalamic paraventricular and dorsomedial nuclei in the female mouse. eNeuro 8:ENEURO.0093-21.2021
    Pubmed KoreaMed CrossRef
  135. Steculorum SM, Ruud J, Karakasilioti I, Backes H, Engström Ruud L, Timper K, Hess ME, Tsaousidou E, Mauer J, Vogt MC, Paeger L, Bremser S, Klein AC, Morgan DA, Frommolt P, Brinkkötter PT, Hammerschmidt P, Benzing T, Rahmouni K, Wunderlich FT, Kloppenburg P, Brüning JC (2016) AgRP neurons control systemic insulin sensitivity via myostatin expression in brown adipose tissue. Cell 165:125-138
    Pubmed KoreaMed CrossRef
  136. Lee JS, Lee EY, Lee HS (2015) Hypothalamic, feeding/arousal-related peptidergic projections to the paraventricular thalamic nucleus in the rat. Brain Res 1598:97-113
    Pubmed CrossRef
  137. Boghossian S, Lemmon K, Park M, York DA (2009) High-fat diets induce a rapid loss of the insulin anorectic response in the amygdala. Am J Physiol Regul Integr Comp Physiol 297:R1302-R1311
    Pubmed CrossRef
  138. Ressler KJ (2010) Amygdala activity, fear, and anxiety: modulation by stress. Biol Psychiatry 67:1117-1119
    Pubmed KoreaMed CrossRef
  139. Hwang YG, Lee HS (2018) Neuropeptide Y (NPY) or cocaine- and amphetamine-regulated transcript (CART) fiber innervation on central and medial amygdaloid neurons that project to the locus coeruleus and dorsal raphe in the rat. Brain Res 1689:75-88
    Pubmed CrossRef
  140. Loh K, Zhang L, Brandon A, Wang Q, Begg D, Qi Y, Fu M, Kulkarni R, Teo J, Baldock P, Brüning JC, Cooney G, Neely GG, Herzog H (2017) Insulin controls food intake and energy balance via NPY neurons. Mol Metab 6:574-584
    Pubmed KoreaMed CrossRef
  141. Leyrer-Jackson JM, Hood LE, Olive MF (2021) Alcohol consumption preferentially activates a subset of pro-opiomelanocortin (POMC) producing neurons targeting the amygdala. Neuropharmacology 195:108674
    Pubmed KoreaMed CrossRef
  142. Metz MJ, Daimon CM, King CM, Rau AR, Hentges ST (2021) Individual arcuate nucleus proopiomelanocortin neurons project to select target sites. Am J Physiol Regul Integr Comp Physiol 321:R982-R989
    Pubmed KoreaMed CrossRef
  143. Guo ZL, Longhurst JC (2010) Activation of reciprocal pathways between arcuate nucleus and ventrolateral periaqueductal gray during electroacupuncture: involvement of VGLUT3. Brain Res 1360:77-88
    Pubmed KoreaMed CrossRef
  144. Sun YG, Gu XL, Yu LC (2007) The neural pathway of galanin in the hypothalamic arcuate nucleus of rats: activation of beta-endorphinergic neurons projecting to periaqueductal gray matter. J Neurosci Res 85:2400-2406
    Pubmed CrossRef
  145. Campos CA, Bowen AJ, Schwartz MW, Palmiter RD (2016) Parabrachial CGRP neurons control meal termination. Cell Metab 23:811-820
    Pubmed KoreaMed CrossRef
  146. Wu Q, Clark MS, Palmiter RD (2012) Deciphering a neuronal circuit that mediates appetite. Nature 483:594-597
    Pubmed KoreaMed CrossRef
  147. Qu N, He Y, Wang C, Xu P, Yang Y, Cai X, Liu H, Yu K, Pei Z, Hyseni I, Sun Z, Fukuda M, Li Y, Tian Q, Xu Y (2020) A POMC-originated circuit regulates stress-induced hypophagia, depression, and anhedonia. Mol Psychiatry 25:1006-1021
    Pubmed KoreaMed CrossRef
  148. Jia X, Chen S, Li X, Tao S, Lai J, Liu H, Huang K, Tian Y, Wei P, Yang F, Lu Z, Chen Z, Liu XA, Xu F, Wang L (2022) Divergent neurocircuitry dissociates two components of the stress response: glucose mobilization and anxiety-like behavior. Cell Rep 41:111586
    Pubmed CrossRef
  149. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ (1988) Anatomy of CNS opioid receptors. Trends Neurosci 11:308-314
    Pubmed CrossRef
  150. Zhao ZQ (2008) Neural mechanism underlying acupuncture analgesia. Prog Neurobiol 85:355-375
    Pubmed CrossRef
  151. Chang S, Kim DH, Jang EY, Yoon SS, Gwak YS, Yi YJ, Lee JY, Ahn SH, Kim JM, Ryu YH, Kim SN, Roh HS, Lee MY, Kim SC, Lee BH, Kim HY, Yang CH (2019) Acupuncture attenuates alcohol dependence through activation of endorphinergic input to the nucleus accumbens from the arcuate nucleus. Sci Adv 5:eaax1342
    Pubmed KoreaMed CrossRef
  152. Krashes MJ, Shah BP, Madara JC, Olson DP, Strochlic DE, Garfield AS, Vong L, Pei H, Watabe-Uchida M, Uchida N, Liberles SD, Lowell BB (2014) An excitatory paraventricular nucleus to AgRP neuron circuit that drives hunger. Nature 507:238-242
    Pubmed KoreaMed CrossRef
  153. Garfield AS, Shah BP, Burgess CR, Li MM, Li C, Steger JS, Madara JC, Campbell JN, Kroeger D, Scammell TE, Tannous BA, Myers MG Jr, Andermann ML, Krashes MJ, Lowell BB (2016) Dynamic GABAergic afferent modulation of AgRP neurons. Nat Neurosci 19:1628-1635
    Pubmed KoreaMed CrossRef
  154. Singh I, Wang L, Xia B, Liu J, Tahiri A, El Ouaamari A, Wheeler MB, Pang ZP (2022) Activation of arcuate nucleus glucagon-like peptide-1 receptor-expressing neurons suppresses food intake. Cell Biosci 12:178
    Pubmed KoreaMed CrossRef
  155. Apovian CM (2016) Obesity: definition, comorbidities, causes, and burden. Am J Manag Care 22(7 Suppl):S176-S185
  156. Hill JO, Wyatt HR, Peters JC (2012) Energy balance and obesity. Circulation 126:126-132
    Pubmed KoreaMed CrossRef
  157. Rossi MA (2023) Control of energy homeostasis by the lateral hypothalamic area. Trends Neurosci 46:738-749
    Pubmed CrossRef
  158. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW (2006) Central nervous system control of food intake and body weight. Nature 443:289-295
    Pubmed CrossRef
  159. Gao Y, Bielohuby M, Fleming T, Grabner GF, Foppen E, Bernhard W, Guzmán-Ruiz M, Layritz C, Legutko B, Zinser E, García-Cáceres C, Buijs RM, Woods SC, Kalsbeek A, Seeley RJ, Nawroth PP, Bidlingmaier M, Tschöp MH, Yi CX (2017) Dietary sugars, not lipids, drive hypothalamic inflammation. Mol Metab 6:897-908
    Pubmed KoreaMed CrossRef
  160. Thaler JP, Yi CX, Schur EA, Guyenet SJ, Hwang BH, Dietrich MO, Zhao X, Sarruf DA, Izgur V, Maravilla KR, Nguyen HT, Fischer JD, Matsen ME, Wisse BE, Morton GJ, Horvath TL, Baskin DG, Tschöp MH, Schwartz MW (2012) Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest 122:153-162
    Pubmed KoreaMed CrossRef
  161. Babcock Gilbert S, Roth LW (2015) Hypothalamic obesity. Minerva Endocrinol 40:61-70
  162. Hochberg I, Hochberg Z (2010) Expanding the definition of hypothalamic obesity. Obes Rev 11:709-721
    Pubmed CrossRef
  163. Nakagawa T, Hosoi T (2023) Recent progress on action and regulation of anorexigenic adipokine leptin. Front Endocrinol (Lausanne) 14:1172060
    Pubmed KoreaMed CrossRef
  164. Obradovic M, Sudar-Milovanovic E, Soskic S, Essack M, Arya S, Stewart AJ, Gojobori T, Isenovic ER (2021) Leptin and obesity: role and clinical implication. Front Endocrinol (Lausanne) 12:585887
    Pubmed KoreaMed CrossRef
  165. Clément K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougnères P, Lebouc Y, Froguel P, Guy-Grand B (1998) A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392:398-401
    Pubmed CrossRef
  166. Kakar N, Ahmad J, Kubisch C, Borck G (2013) Exon skipping and severe childhood-onset obesity caused by a leptin receptor mutation. Am J Med Genet A 161A:2672-2674
    Pubmed CrossRef
  167. Stäubert C, Tarnow P, Brumm H, Pitra C, Gudermann T, Grüters A, Schöneberg T, Biebermann H, Römpler H (2007) Evolutionary aspects in evaluating mutations in the melanocortin 4 receptor. Endocrinology 148:4642-4648
    Pubmed CrossRef
  168. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P (2000) Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 106:253-262
    Pubmed KoreaMed CrossRef
  169. Vaisse C, Clement K, Guy-Grand B, Froguel P (1998) A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 20:113-114
    Pubmed CrossRef
  170. Yeo GS, Farooqi IS, Aminian S, Halsall DJ, Stanhope RG, O'Rahilly S (1998) A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 20:111-112
    Pubmed CrossRef
  171. del Giudice EM, Santoro N, Cirillo G, D'Urso L, Di Toro R, Perrone L (2001) Mutational screening of the CART gene in obese children: identifying a mutation (Leu34Phe) associated with reduced resting energy expenditure and cosegregating with obesity phenotype in a large family. Diabetes 50:2157-2160
    Pubmed CrossRef
  172. Yanik T, Dominguez G, Kuhar MJ, Del Giudice EM, Loh YP (2006) The Leu34Phe ProCART mutation leads to cocaine- and amphetamine-regulated transcript (CART) deficiency: a possible cause for obesity in humans. Endocrinology 147:39-43
    Pubmed CrossRef
  173. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Grüters A (1998) Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19:155-157
    Pubmed CrossRef
  174. Krude H, Biebermann H, Schnabel D, Tansek MZ, Theunissen P, Mullis PE, Grüters A (2003) Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. J Clin Endocrinol Metab 88:4633-4640
    Pubmed CrossRef
  175. Jackson RS, Creemers JW, Farooqi IS, Raffin-Sanson ML, Varro A, Dockray GJ, Holst JJ, Brubaker PL, Corvol P, Polonsky KS, Ostrega D, Becker KL, Bertagna X, Hutton JC, White A, Dattani MT, Hussain K, Middleton SJ, Nicole TM, Milla PJ, Lindley KJ, O'Rahilly S (2003) Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J Clin Invest 112:1550-1560
    Pubmed KoreaMed CrossRef
  176. Jackson RS, Creemers JW, Ohagi S, Raffin-Sanson ML, Sanders L, Montague CT, Hutton JC, O'Rahilly S (1997) Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 16:303-306
    Pubmed CrossRef
  177. Füredi N, Mikó A, Gaszner B, Feller D, Rostás I, Tenk J, Solymár M, Balaskó M, Pétervári E (2018) Activity of the hypothalamic melanocortin system decreases in middle-aged and increases in old rats. J Gerontol A Biol Sci Med Sci 73:438-445
    Pubmed CrossRef
  178. Gruenewald DA, Matsumoto AM (1991) Age-related decrease in proopiomelanocortin gene expression in the arcuate nucleus of the male rat brain. Neurobiol Aging 12:113-121
    Pubmed CrossRef
  179. Pétervári E, Garami A, Soós S, Székely M, Balaskó M (2010) Age-dependence of alpha-MSH-induced anorexia. Neuropeptides 44:315-322
    Pubmed CrossRef
  180. Anthwal N, Pelling M, Claxton S, Mellitzer G, Collin C, Kessaris N, Richardson WD, Gradwohl G, Ang SL (2013) Conditional deletion of neurogenin-3 using Nkx2.1iCre results in a mouse model for the central control of feeding, activity and obesity. Dis Model Mech 6:1133-1145
    Pubmed KoreaMed CrossRef
  181. Pelling M, Anthwal N, McNay D, Gradwohl G, Leiter AB, Guillemot F, Ang SL (2011) Differential requirements for neurogenin 3 in the development of POMC and NPY neurons in the hypothalamus. Dev Biol 349:406-416
    Pubmed CrossRef
  182. Jing E, Nillni EA, Sanchez VC, Stuart RC, Good DJ (2004) Deletion of the Nhlh2 transcription factor decreases the levels of the anorexigenic peptides alpha melanocyte-stimulating hormone and thyrotropin-releasing hormone and implicates prohormone convertases I and II in obesity. Endocrinology 145:1503-1513
    Pubmed CrossRef
  183. Al Rayyan N, Zhang J, Burnside AS, Good DJ (2014) Leptin signaling regulates hypothalamic expression of nescient helix-loop-helix 2 (Nhlh2) through signal transducer and activator 3 (Stat3). Mol Cell Endocrinol 384:134-142
    Pubmed KoreaMed CrossRef
  184. Carraro RS, Nogueira GA, Sidarta-Oliveira D, Gaspar RS, Dragano NR, Morari J, Bobbo VCD, Araujo EP, Mendes NF, Zanesco AM, Tobar N, Ramos CD, Toscaro JM, Bajgelman MC, Velloso LA (2021) Arcuate nucleus overexpression of NHLH2 reduces body mass and attenuates obesity-associated anxiety/depression-like behavior. J Neurosci 41:10004-10022
    Pubmed KoreaMed CrossRef
  185. Good DJ, Porter FD, Mahon KA, Parlow AF, Westphal H, Kirsch IR (1997) Hypogonadism and obesity in mice with a targeted deletion of the Nhlh2 gene. Nat Genet 15:397-401
    Pubmed CrossRef
  186. Topaloglu AK, Simsek E, Kocher MA, Mammadova J, Bober E, Kotan LD, Turan I, Celiloglu C, Gurbuz F, Yuksel B, Good DJ (2022) Inactivating NHLH2 variants cause idiopathic hypogonadotropic hypogonadism and obesity in humans. Hum Genet 141:295-304
    Pubmed CrossRef
  187. Loid P, Mustila T, Mäkitie RE, Viljakainen H, Kämpe A, Tossavainen P, Lipsanen-Nyman M, Pekkinen M, Mäkitie O (2020) Rare variants in genes linked to appetite control and hypothalamic development in early-onset severe obesity. Front Endocrinol (Lausanne) 11:81
    Pubmed KoreaMed CrossRef
  188. Nasif S, de Souza FS, González LE, Yamashita M, Orquera DP, Low MJ, Rubinstein M (2015) Islet 1 specifies the identity of hypothalamic melanocortin neurons and is critical for normal food intake and adiposity in adulthood. Proc Natl Acad Sci U S A 112:E1861-E1870
    Pubmed KoreaMed CrossRef
  189. Borman AD, Pearce LR, Mackay DS, Nagel-Wolfrum K, Davidson AE, Henderson R, Garg S, Waseem NH, Webster AR, Plagnol V, Wolfrum U, Farooqi IS, Moore AT (2014) A homozygous mutation in the TUB gene associated with retinal dystrophy and obesity. Hum Mutat 35:289-293
    Pubmed KoreaMed CrossRef
  190. Nies VJM, Struik D, Wolfs MGM, Rensen SS, Szalowska E, Unmehopa UA, Fluiter K, van der Meer TP, Hajmousa G, Buurman WA, Greve JW, Rezaee F, Shiri-Sverdlov R, Vonk RJ, Swaab DF, Wolffenbuttel BHR, Jonker JW, van Vliet-Ostaptchouk JV (2018) TUB gene expression in hypothalamus and adipose tissue and its association with obesity in humans. Int J Obes (Lond) 42:376-383
    Pubmed CrossRef
  191. Moir L, Bochukova EG, Dumbell R, Banks G, Bains RS, Nolan PM, Scudamore C, Simon M, Watson KA, Keogh J, Henning E, Hendricks A, O'Rahilly S, Barroso I, Sullivan AE, Bersten DC, Whitelaw ML, Kirsch S, Bentley E, Farooqi IS, Cox RD; UK10K consortium (2017) Disruption of the homeodomain transcription factor orthopedia homeobox (Otp) is associated with obesity and anxiety. Mol Metab 6:1419-1428
    Pubmed KoreaMed CrossRef
  192. Brioude F, Bouligand J, Francou B, Fagart J, Roussel R, Viengchareun S, Combettes L, Brailly-Tabard S, Lombès M, Young J, Guiochon-Mantel A (2013) Two families with normosmic congenital hypogonadotropic hypogonadism and biallelic mutations in KISS1R (KISS1 receptor): clinical evaluation and molecular characterization of a novel mutation. PLoS One 8:e53896
    Pubmed KoreaMed CrossRef
  193. Hu KL, Chen Z, Li X, Cai E, Yang H, Chen Y, Wang C, Ju L, Deng W, Mu L (2022) Advances in clinical applications of kisspeptin-GnRH pathway in female reproduction. Reprod Biol Endocrinol 20:81
    Pubmed KoreaMed CrossRef
  194. Silveira LG, Noel SD, Silveira-Neto AP, Abreu AP, Brito VN, Santos MG, Bianco SD, Kuohung W, Xu S, Gryngarten M, Escobar ME, Arnhold IJ, Mendonca BB, Kaiser UB, Latronico AC (2010) Mutations of the KISS1 gene in disorders of puberty. J Clin Endocrinol Metab 95:2276-2280
    Pubmed KoreaMed CrossRef
  195. Topaloglu AK, Tello JA, Kotan LD, Ozbek MN, Yilmaz MB, Erdogan S, Gurbuz F, Temiz F, Millar RP, Yuksel B (2012) Inactivating KISS1 mutation and hypogonadotropic hypogonadism. N Engl J Med 366:629-635
    Pubmed CrossRef
  196. Teles MG, Bianco SD, Brito VN, Trarbach EB, Kuohung W, Xu S, Seminara SB, Mendonca BB, Kaiser UB, Latronico AC (2008) A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med 358:709-715
    Pubmed KoreaMed CrossRef
  197. Francou B, Bouligand J, Voican A, Amazit L, Trabado S, Fagart J, Meduri G, Brailly-Tabard S, Chanson P, Lecomte P, Guiochon-Mantel A, Young J (2011) Normosmic congenital hypogonadotropic hypogonadism due to TAC3/TACR3 mutations: characterization of neuroendocrine phenotypes and novel mutations. PLoS One 6:e25614
    CrossRef
  198. Gianetti E, Tusset C, Noel SD, Au MG, Dwyer AA, Hughes VA, Abreu AP, Carroll J, Trarbach E, Silveira LF, Costa EM, de Mendonça BB, de Castro M, Lofrano A, Hall JE, Bolu E, Ozata M, Quinton R, Amory JK, Stewart SE, Arlt W, Cole TR, Crowley WF, Kaiser UB, Latronico AC, Seminara SB (2010) TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood. J Clin Endocrinol Metab 95:2857-2867
    Pubmed KoreaMed CrossRef
  199. Topaloglu AK, Reimann F, Guclu M, Yalin AS, Kotan LD, Porter KM, Serin A, Mungan NO, Cook JR, Imamoglu S, Akalin NS, Yuksel B, O'Rahilly S, Semple RK (2009) TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for neurokinin B in the central control of reproduction. Nat Genet 41:354-358
    Pubmed KoreaMed CrossRef
  200. Young J, Bouligand J, Francou B, Raffin-Sanson ML, Gaillez S, Jeanpierre M, Grynberg M, Kamenicky P, Chanson P, Brailly-Tabard S, Guiochon-Mantel A (2010) TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans. J Clin Endocrinol Metab 95:2287-2295
    Pubmed CrossRef
  201. Abreu AP, Dauber A, Macedo DB, Noel SD, Brito VN, Gill JC, Cukier P, Thompson IR, Navarro VM, Gagliardi PC, Rodrigues T, Kochi C, Longui CA, Beckers D, de Zegher F, Montenegro LR, Mendonca BB, Carroll RS, Hirschhorn JN, Latronico AC, Kaiser UB (2013) Central precocious puberty caused by mutations in the imprinted gene MKRN3. N Engl J Med 368:2467-2475
    Pubmed KoreaMed CrossRef
  202. Dauber A, Cunha-Silva M, Macedo DB, Brito VN, Abreu AP, Roberts SA, Montenegro LR, Andrew M, Kirby A, Weirauch MT, Labilloy G, Bessa DS, Carroll RS, Jacobs DC, Chappell PE, Mendonca BB, Haig D, Kaiser UB, Latronico AC (2017) Paternally inherited DLK1 deletion associated with familial central precocious puberty. J Clin Endocrinol Metab 102:1557-1567
    Pubmed KoreaMed CrossRef

Print ISSN : 1226-2560

Online ISSN : 2093-8144

© 2019. Experimental Neurobiology: the official journal of the Korean Society for Brain and Neural Sciences & the Korean Society for Neurodegenerative Disease.